Hate the corporate world....so back to trading and peace and quiet :-)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yea would have kicked the boy to the curb in Montreal BUT definitely keep those thigh highs
STAU I really like this stock!!
Experience?!?!?! Spoochy you giving away secrets? <listening intently> lol
But the powdered and diapering issue image didn't do a thing for me now give me a whip and they'll have a red azzzz........wow that makes me feel better.
oh wow is that BDSM central? I have a friend that lives up there let me ask him lol
Mmmmmmmmmmmmm I'm buying or maybe I'll buy a shell and r/m a BDSM company into it. lol
My dream is to one day have a swiss bank account, right now it just looks like swiss cheese
Wow if I could do that I would be quite flexible hehehe
You know one of these days he's going to be right.......then he can say he told us so lol I love gloomy ole BT!
ROFLMAO boy did I just insert both my feet in my mouth
I would love it Spoochy
You only have worry about me eating you for 1 week then I'm back to normal weeeeeeeeeeee but it could be a very dangerous week for someone lol
Dang it Hawks you've ruin a perfectly foul mood by making me laugh!! lmao
TOP 5 % GAINERS FOR TODAY!
QSGIQ 130.43% pmlg,tupacmo,quik18holes,BlackWidow1,MarketGeometry,mikek83,khallis,BlueChip,buccaneer1961,hdsstocks,bdr,suhawh0
EPCG 100.00% soybanzai
STAU 85.71% shankapotamus,CHART PLAYER,Tater salad
OPTZ 48.44% i_like_bb_stock,vietmunki
WTCT 46.67% dblue987,hArdCoReJESUSfreAK
Your a dirty mean nasty old man.......done here! See ya'll!
Thank you verycareful had 2 sources (ihub historical and my QT that had .0001) so used those then sorry it had a R/S. Your entry in contest for Friday's close has been corrected to reflect .02 Sorry for confusion
Time & Sales
Price Size Exch Time
.02 37000 OTO 10/08
0.02 3504 OTO 10/08
0.015 9740 OTO 10/08
0.02 25000 OTO 10/08
0.02 4000 OTO 10/08
w 0.02 16000 OTO 10/08
0.02 9336 OTO 10/08
0.018 3800 OTO 10/08
http://otcbb.com/asp/Info_Center.asp
lol Thought the name change was better suited to me
Thought you had a new a mod........I don't talk about other spiders :-p
Actually they had a R/S of 1/500 and ihub had not adjusted the closing price on Friday to reflect the R/S so accordingly the adjusted closing price on Friday was .05. Which makes IHGP actually down 40%.
But it was nice to day dream about hitting a huger gainer like that (not holding any).
Hey Wolfy!!!! lmao
You know I'm all about the money....BZCN looks like a slot machine with positive pay-offs
Picked up a few of those last week on your chatter about seasonal run
Noticed that one Hcotton......looks like it's shaping up to be a nice play.
STAU if you'd bought on the following post you could have bought @ .0005...........right here on Teffys board!!!
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=55314491&txt2find=stau
Morning Suebee
WOW QSGIQ HOD .244 currently .20 x .21 up 73.91% from Friday's close weeeeeeeeeeeee
And a Good Morning Baggas crew.........this week is going to be a definite money maker......everyday will be like hitting the jackpot on the slot machines lol
Well actually lukewarm this morning.......to tired to be hot lmao
BFHJ News
(In this weeks members picks)
http://ih.advfn.com/p.php?pid=nmona&article=44729739&symbol=NO^BFHJ
Grupo Beneficial Announces That Its Casino Goes Live
BENEFICIAL HOLDINGS INC (OTC) (USOTC:BFHJ)
Intraday Stock Chart
Today : Monday 11 October 2010
Click Here for more BENEFICIAL HOLDINGS INC (OTC) Charts.
Grupo Beneficial, S.A., subsidiary of Beneficial Holdings, Inc. (PINKSHEETS: BFHJ), announces that its bet.cr by Beneficial casino is now officially live and accepting deposits from non-United States residents.
Potential customers can now make deposits to bet.cr by Beneficial and play the games for real money. There is a choice of a downloadable version of the software or flash-based online games.
The downloadable software is fast and efficient and contains no spyware or adware. The software uses very little memory and creates a direct connection between you and the casino. The software updates itself automatically and is easy to use. Players wishing to experience the full bet.cr by Beneficial can download the software at http://www.bet.cr/download.php . Players wishing to play only the flash
-based games should visit the main homepage at http://www.bet.cr and clicking on the orange message that says, "Play our instant browser based games now."
There is a progressive jackpot that presently totals over a million dollars. Some of the slot games have jackpots that currently exceed two-hundred thousand dollars.
Over the next week, our engineers will be finalizing disk that will be mailed to those who requested it. The disk will allow potential players to receive the latest software update and to play games for fun or money. The software will also be made available on various internet sites.
Additional modifications to the site may occur in the near future; however, the software is working and will update itself and incorporate all changes that are made later on.
ABOUT BENEFICIAL HOLDINGS, INC.
Beneficial Holdings, Inc. is a casino investment holding company, specializing in acquiring undervalued gaming assets. The Company owns a hotel in Managua, a restaurant, bar, and casino also in Managua, and a slot parlor in Masaya, Nicaragua. The Company has agreements in place to build another hotel in El Crucero, Nicaragua, and is negotiating several Central American gaming projects.
This release does not constitute an offer of securities for sale. It contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve risks and uncertainties that could cause results to differ. Statements are based on information available as of today and the company undertakes no obligation to update statements to reflect future occurrences.
Media Relations
Beneficial Marketing, Inc.
www.beneficialholdings.info
www.bet.cr
www.hotelbeneficial.com
+505-8367-3333 Telephone
AVEW News
(In this weeks members picks)
http://ih.advfn.com/p.php?pid=nmona&article=44734456&symbol=NO^AVEW
ActionView International, Inc. Chairman Discusses Reporting Status and Expansion of Board of Directors
Date : 10/11/2010 @ 7:00AM
Source : GlobeNewswire Inc.
Stock : ActionView International (AVEW)
Quote : 0.0068 0.0 (0.00%) @ 8:04AM
ActionView International, Inc. Chairman Discusses Reporting Status and Expansion of Board of Directors
Actionview International (OTC) (USOTC:AVEW)
Intraday Stock Chart
Today : Monday 11 October 2010
Click Here for more Actionview International (OTC) Charts.
ActionView International, Inc. (Pink Sheets:AVEW) Chairman and Chief Executive Officer, Gary Nerison, today discussed the company's current reporting status by commenting, "As a company we are committed to providing our shareholders with accurate and timely information to better help them appreciate where ActionView is headed. At the same time, we are sensitive to the price fluctuations that often accompany thinly trading stocks and try to make sure that price speculation by foreign investors is minimized. With that in mind, we believe that the company is now better positioned to protect our long-term shareholders and we are pleased to announce that we will be filing our current report within the next few days. Our expectation is that we will maintain a current reporting status indefinitely as we work towards moving towards a 'fully reporting' status and a listing on a higher exchange."
Mr. Nerison also commented on the proposed changes to company's board of directors, "With ActionView now generating stable revenues through its subsidiary, MatchFights, LLC, and the expansion of the WCFC brand into international markets through the televised distribution of pre-recorded content, we are now in a position to expand our board of directors. We are in discussion with industry professionals that can bring experience in both sports entertainment and mixed martial arts production with a goal of bolstering the management team and moving the company rapidly forward towards meeting its business goals. We anticipate announcing the appointment of two additional board members immediately following the October 16th event at the Rail Event Center in Salt Lake City."
Mr. Nerison also expressed his appreciation for current management, "We are deeply appreciative of the personal sacrifices of everyone involved with building ActionView and MatchFights. It's no simple task to build a brand from scratch and make significant inroads in an industry known for being exclusive. We're proud of the progress made so far and are glad to be able to now bring additional support to our board and management."
In discussing financing options, Mr. Nerison explained, "ActionView is well positioned financially so that we do not expect the need to raise any additional funds through the end of the year. We have been careful thus far in ensuring that dilution to our shareholders is kept at a minimum - something we as a Board are very proud of. Apart from the mandatory, timed conversion of our preferred stock, very few shares have been issued and none have been added to the float, thus avoiding the downward pressure of having multiple sellers out there with below-market stock."
ActionView International's wholly-owned MatchFights subsidiary delivers the most exciting brand of full contact fighting under its World Championship Full Contact (WCFC) banner. MatchFights' events are broadcast live in television quality to a worldwide audience over the Internet, and revenue is derived from pay-per-view buys.
Fight fans, fighters, promoters, trainers and ring girls are encouraged to visit the WCFC website at www.wcfc.com to set up a personal profile and join the first and only comprehensive content driven MMA web community dedicated to fighting. The site harnesses the power of social networks, allowing users to connect and share information about their favorite fighters, fights and events. A comprehensive marketing program is expected to result in the www.wcfc.com becoming the dominant fighting website in the world and draw consumers for WCFC events broadcast over the Internet.
Shareholders and anyone interested in monitoring the progress of the company are encouraged to subscribe to the electronic mailing list by forwarding their email address to investors@actionviewint.com.
About ActionView International, Inc.
ActionView International, its wholly owned MatchFights, LLC subsidiary and the World Championship Full Contact brand deliver exciting, live, pay-per-view events in an interactive venue over the Internet to a global audience. Revenue is derived from pay-per-view buys. The live events have broad appeal and may include elements of fighting, music, ring girl contests, and other live entertainment as part of the broadcast. For additional information about MatchFights and its World Championship Full Contact brand, please visit www.wcfc.com and join the world's premier fight-based network.
CONTACT: ActionView International, Inc.
Shareholder Relations
1-800-480-2690
investors@actionviewint.com
ALXA News
(In this weeks members picks)
http://ih.advfn.com/p.php?pid=nmona&article=44735012&symbol=N^ALXA
Alexza To Meet With FDA To Address Concerns On Bipolar Drug
Alexza (NASDAQ:ALXA)
Intraday Stock Chart
Today : Monday 11 October 2010
Click Here for more Alexza Charts.
Alexza Pharmaceuticals Inc. (ALXA) said the Food and Drug Administration has decided a schizophrenic and bipolar disorder treatment isn't ready for approval, citing safety concerns.
Valeant Pharmaceuticals International Inc. (VRX) has agreed to commercialize the treatment, Alexza's lead candidate, in the U.S. and Canada. The drug is well-known and has been used for years, but combined with Alexza's inhaler delivery system it is proposed to provide rapid action and simple administration.
The FDA had safety concerns--decreases in forced expiratory volume and a measure of lung function that were observed early-stage testing, Alexza said. Suitability and stability worries also arose from the agency's pre-approval manufacturing inspection.
Officials from the company and the FDA will meet to discuss the next course.
Alexza shares closed Friday at $3.03 while Valeant finished at $26.84. Neither was active premarket.
-By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; matthew.jarzemsky@dowjones.com
ALXA News
(In this weeks members picks)
http://ih.advfn.com/p.php?pid=nmona&article=44733962&symbol=N^ALXA
Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
Date : 10/11/2010 @ 6:30AM
Source : PR Newswire
Stock : Alexza (ALXA)
Quote : 3.03 0.0 (0.00%) @ 7:22AM
Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
Alexza (NASDAQ:ALXA)
Intraday Stock Chart
Today : Monday 11 October 2010
Click Here for more Alexza Charts.
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA or Agency) regarding its New Drug Application (NDA) for AZ-004 (Staccato® loxapine), submitted as Adusuveâ„¢ Staccato® (loxapine) inhalation aerosol, 5 mg and 10 mg. A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form. AZ-004 is being developed for the rapid treatment of agitation in schizophrenia or bipolar disorder patients.
In the CRL, the FDA stated that their primary clinical safety concern was related to data from the three Phase 1 pulmonary safety studies with AZ-004. This concern was primarily based on observed, dose-related post-dose decreases in forced expiratory volume in one second, or FEV1, a standard measure of lung function, in healthy subjects and in subjects with COPD and asthma. The agency also noted that decreases in FEV1 were recorded in subjects who were administered device-only, placebo versions of AZ-004. Alexza intends to meet with the FDA in the near future to discuss steps to address this FDA concern. As Alexza has previously reported, there were no serious or severe respiratory adverse events in these trials or reported in the two Phase 3 clinical trials of AZ-004. All respiratory symptoms that developed after treatment in the Phase 1 subjects with COPD and asthma were either self-limiting or readily managed with an inhaled bronchodilator.
The CRL also raised issues relating to the suitability of the stability studies undertaken by Alexza and certain other items relating to the agency's recently completed pre-approval manufacturing inspection. Because AZ-004 incorporates a novel delivery system, the CRL also included input from FDA's Center for Devices and Radiological Health (CDRH). CDRH requested a human factors study and related analysis to validate that the product can be used effectively in the proposed clinical setting. CDRH also requested further bench testing of the product under an additional "worst-case" manufacturing scenario.
"We are reviewing the Complete Response Letter and plan to meet with the FDA as soon as possible to discuss the Agency's pulmonary safety concern. Alexza shares the agency's deep interest in patient safety, and believes the pulmonary data is supportive of the safety of AZ-004. We look forward to discussing the appropriate way to address this issue," said Thomas B. King, Alexza President and CEO. "We are also undertaking steps to address the other items raised in the CRL. We appreciate the FDA's review of the first NDA for our novel Staccato technology, and we expect to work closely with FDA to resolve the issues raised in the Complete Response Letter. Alexza continues to believe in the safety and efficacy of AZ-004 based on the comprehensive clinical development program we have conducted."
Conference Call Information
The Company will host an investor conference call and live webcast today, Monday, October 11, 2010 at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. The conference call, live webcast and archived replay are open to all interested parties.
To access the conference call via the Internet, go to www.alexza.com, under the "Investor Relations" link. Please join the call at least 15 minutes prior to the start of the call to ensure time for any software downloads that may be required. Interested parties may also pre-register to avoid pre-call delays at https://www.theconferencingservice.com/prereg/key.process?key=PFAUVPB9C. A replay of the call will be available for two weeks following the event.
To access the live conference call via phone, dial 888-713-4217. International callers may access the live call by dialing 617-213-4869. The reference number to enter the call is 20601442.
The replay of the conference call may be accessed via the Internet, at www.alexza.com, or via phone at 888-286-8010 for domestic callers or 617-801-6888 for international callers. The reference number for the replay of the call is 36572489.
About Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals is a pharmaceutical company focused on the research, development and commercialization of novel, proprietary products for the acute treatment of central nervous system conditions. Alexza's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)
AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, submitted a New Drug Application in December 2009. In February 2010, Alexza established a partnership with Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, to develop and commercialize AZ-004 in the U.S. and Canada. Biovail recently completed a merger with Valeant Pharmaceuticals International.
For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.
Safe Harbor Statement
This press release includes forward-looking statements regarding the development and safety of the Company's product candidates and technologies. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ materially from those expressed or implied by such forward-looking statements. These and other risks concerning Alexza's business are described in additional detail in the Company's Annual Report on Form 10-K for the year ended December 31, 2009, and the Company's other Periodic and Current Reports filed with the Securities and Exchange Commission including the risks under the headings: "Regulatory authorities may not approve our product candidates even if they meet safety and efficacy endpoints in clinical trials.", "We have a history of net losses. We expect to continue to incur substantial and increasing net losses for the foreseeable future, and we may never achieve or maintain profitability.", "We will need substantial additional capital in the future. If additional capital is not available, we will have to delay, reduce or cease operations.", and "Unless our preclinical studies demonstrate the safety of our product candidates, we will not be able to commercialize our product candidates.". Forward-looking statements contained in this announcement are made as of this date, and we undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
SOURCE Alexza Pharmaceuticals, Inc.
You better starting looking beyond next season.......ah maybe you'll get lucky season after next..........just maybe lol
How ya doin Tater?!?!?! Next week is going to be sooooooooooooooooo hot lots of money to be made!
There was a time when the Cowboys was a golden team but those were in there yesteryear's BUT then again I've never been a Cowboys fan.......give me the Colts and Titan every year I'm faithful to my teams
Hey how'd your Cowgirls do tonite?!?!?!? OOppppsss never mind I watched the game and my Titans whipped your azzzzzzzzzz hehehehe
Oh yeaaaaaaaaaaaaaaaaaaaa was a beautiful sight to behold hehehehe Damn those cheerleaders can't handle the football very well and the head cheerleader Romo can't remember the routines lol